Pharmafile Logo
Pharmafocus logo
Advanced Search

Lipitor

Showing 15 posts of 38 posts found.

Teva launches first generic Lipitor in UK

May 8, 2012
Sales and Marketing Lipitor, NHS, Pfizer, Teva, atorvastatin

Teva has launched the first generic Lipitor in the UK on the day the drug loses its patent protection.  The …

News
Ian Read

Lipitor losses hit Pfizer

May 2, 2012
Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry

Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …

News
Pfizer picture

Pfizer sells nutrition business to Nestlé for $11.9 billion

April 23, 2012
Business Services, Sales and Marketing Business, Lipitor, Pfizer, nestle, nutrition

Pfizer has sold its nutrition business to Nestlé for $11.85 billion in cash. Pfizer Nutrition is a leading global pediatric …

News
Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012
Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …

News

Ranbaxy launches generic Lipitor in Europe

March 6, 2012
Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics

Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date.  The Indian …

News
Lipitor UK video

Keep prescribing Lipitor – the generics are nearly here, says Pfizer

January 5, 2012
Medical Communications, Sales and Marketing Lipitor, NHS, Pfizer, statin prescribing

Pfizer has launched a campaign to persuade UK doctors to keep prescribing Lipitor ahead of its patent expiry in May. …

News
Teva picture

Teva gains tentative approval to sell generic Lipitor in 2012

December 5, 2011
Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Teva has gained a tentative approval by the FDA to sell its generic form of Pfizer’s blockbuster statin Lipitor next …

News

FDA approves Ranbaxy’s generic Lipitor

December 1, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

The FDA will allow Ranbaxy to develop a generic version of Pfizer’s blockbuster statin Lipitor. The firm has received final …

News

Watson launches first generic Lipitor in US

November 30, 2011
Sales and Marketing Lipitor, Pfizer, Watson, atorvastin

Watson Pharmaceuticals has launched its generic version of Pfizer’s blockbuster statin Lipitor as the drug goes off patent in the …

News

The changing of the guard – Q3 round up

November 25, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy

 PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …

Feature

Pfizer hatches mail order plan for Lipitor

November 23, 2011
Sales and Marketing Lipitor, Pfizer, US, generics

Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …

News
Ranbayx image

Ranbaxy to collaborate with Teva on generic Lipitor in US?

November 7, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …

News
pfizer_hq_street_web

Prevnar and Lyrica lift Pfizer results

November 1, 2011
Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry

Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter.  …

News
AstraZeneca's Crestor (rosuvastatin)

Crestor fails head-to-head test against Lipitor

September 2, 2011
Sales and Marketing Crestor, Lipitor

AstraZeneca’s cholesterol drug Crestor has failed to show it can stop artery disease better than Pfizer’s Lipitor. The new study …

News

Pfizer’s ageing blockbuster Lipitor wins $770m paediatric boost

July 11, 2011
Sales and Marketing Lipitor, Pfizer, paediatric trials

Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026